{"id":613,"date":"2021-10-26T15:04:15","date_gmt":"2021-10-26T15:04:15","guid":{"rendered":"https:\/\/medicalmarijuanainc.com\/?p=49335"},"modified":"2021-10-26T15:04:15","modified_gmt":"2021-10-26T15:04:15","slug":"medical-marijuana-inc-subsidiary-kannaway-wins-high-administrative-court-case-to-legally-import-cbd-oil-in-finland","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2021\/10\/26\/medical-marijuana-inc-subsidiary-kannaway-wins-high-administrative-court-case-to-legally-import-cbd-oil-in-finland\/","title":{"rendered":"Medical Marijuana, Inc. Subsidiary Kannaway\u00ae Wins High Administrative Court Case to Legally Import CBD Oil in Finland"},"content":{"rendered":"
[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row admin_label=”row” _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text admin_label=”Text” _builder_version=”3.27.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”]SAN DIEGO, CA, Oct. 26, 2021 (GLOBE NEWSWIRE) — via\u00a0NewMediaWire<\/u><\/a>\u00a0—\u00a0Medical Marijuana, Inc.<\/u><\/a>\u00a0(OTC: MJNA) (the \u201cCompany\u201d), the first-ever publicly traded cannabis company in the United States that launched the world\u2019s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company\u2019s subsidiary\u00a0Kannaway\u00ae<\/a>\u00a0has won a historic court case in Finland proving the legality of the importation of the Company\u2019s cannabidiol (CBD) oil.<\/p>\n \u201cWe have been a leader in bringing CBD to Finland, as well as to many other countries across Europe,\u201d said Kannaway\u00ae CEO Blake Schroeder. \u201cWe knew that our operations and sales were legal in Finland but receiving this ruling from the Finnish High Supreme Administrative Court is promising for the future of our company and the entire industry. We are well on our way to becoming the first truly global cannabis company in the world.\u201d<\/p>\n In 2018, Finnish Customs confiscated a bottle of\u00a0Kannaway\u00ae Pure Gold<\/a>\u00a0and claimed that it was illegally imported since FIMEA, the Finnish Medicines Agency, lists CBD as a medicinal ingredient, causing the Finnish Customs Authority to take a \u201cblanket approach\u201d in treating all CBD products like medicines. On Friday, October 22, 2021, the Finnish Supreme Administrative Court declared that any product, according to EU directives, would need to be classified as a medicinal product on a case-by-case basis with specific claims on therapeutic effects, dosage and supporting evidence. In this case, the Supreme Administrative Court has declared that Kannaway\u00ae Pure Gold hemp oil is not a medicinal product.<\/p>\n \u201cThis is a huge win for Kannaway. Certainly, the European hemp industry will also benefit, but we are proud that it is our Company that took action, fought the battle and won. We hope that this sets an important precedent for other EU jurisdictions where national medicine agencies have held a similar opinion,\u201d said Kannaway\u00ae Managing Director of International Janne Heimonen. \u201cWe have been fighting for many years now to prove that we are not, by law, selling medicine, but that our CBD oil is a nutritional supplement.\u201d<\/p>\n About Kannaway\u00ae<\/b><\/p>\n Kannaway\u00ae<\/a>\u00a0is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway\u00ae currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.<\/p>\n About Medical Marijuana, Inc.<\/b><\/p>\n We are a company of firsts\u00ae<\/a>. Medical Marijuana, Inc. (MJNA<\/a>) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by\u00a0Kannaway\u00ae<\/a>\u00a0and\u00a0HempMeds\u00ae<\/a>; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including\u00a0AXIM\u00ae Biotechnologies, Inc<\/a>.<\/a>\u00a0and\u00a0<\/a>Neuropathix<\/a>. Medical Marijuana, Inc. was named a top CBD producer by\u00a0CNBC<\/a>. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product\u00a0Real Scientific Hemp Oil<\/a>\u00a0has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.<\/p>\n Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at\u00a0OTCMarkets.com<\/a>\u00a0or by visiting\u00a0www.medicalmarijuanainc.com<\/a>. To see Medical Marijuana, Inc.’s corporate video,\u00a0click here<\/a>.<\/p>\n FORWARD-LOOKING DISCLAIMER<\/b><\/p>\n This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.<\/p>\n FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE<\/b><\/p>\n These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.<\/p>\n LEGAL DISCLOSURE<\/b><\/p>\n Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.<\/p>\n CONTACT:<\/b><\/p>\n Public Relations Contact:<\/b><\/p>\n Kathryn Brown Investor Relations Contact:<\/b><\/p>\n P.\u00a0(858) 283-4016 [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" SAN DIEGO, CA, Oct. 26, 2021 (GLOBE NEWSWIRE) — via\u00a0NewMediaWire\u00a0—\u00a0Medical Marijuana, Inc.\u00a0(OTC: MJNA) (the \u201cCompany\u201d), the first-ever publicly traded cannabis company in the United States that launched the world\u2019s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company\u2019s subsidiary\u00a0Kannaway\u00ae\u00a0has won a historic court case in Finland proving the legality of the […]<\/p>\n","protected":false},"author":1,"featured_media":614,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"SAN DIEGO, CA, Oct. 26, 2021 (GLOBE NEWSWIRE) -- via\u00a0NewMediaWire<\/u><\/a>\u00a0--\u00a0Medical Marijuana, Inc.<\/u><\/a>\u00a0(OTC: MJNA) (the \u201cCompany\u201d), the first-ever publicly traded cannabis company in the United States that launched the world\u2019s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company\u2019s subsidiary\u00a0Kannaway\u00ae<\/a>\u00a0has won a historic court case in Finland proving the legality of the importation of the Company\u2019s cannabidiol (CBD) oil.\r\n\r\n\u201cWe have been a leader in bringing CBD to Finland, as well as to many other countries across Europe,\u201d said Kannaway\u00ae CEO Blake Schroeder. \u201cWe knew that our operations and sales were legal in Finland but receiving this ruling from the Finnish High Supreme Administrative Court is promising for the future of our company and the entire industry. We are well on our way to becoming the first truly global cannabis company in the world.\u201d\r\n In 2018, Finnish Customs confiscated a bottle of\u00a0Kannaway\u00ae Pure Gold<\/a>\u00a0and claimed that it was illegally imported since FIMEA, the Finnish Medicines Agency, lists CBD as a medicinal ingredient, causing the Finnish Customs Authority to take a \u201cblanket approach\u201d in treating all CBD products like medicines. On Friday, October 22, 2021, the Finnish Supreme Administrative Court declared that any product, according to EU directives, would need to be classified as a medicinal product on a case-by-case basis with specific claims on therapeutic effects, dosage and supporting evidence. In this case, the Supreme Administrative Court has declared that Kannaway\u00ae Pure Gold hemp oil is not a medicinal product.<\/p>\r\n \u201cThis is a huge win for Kannaway. Certainly, the European hemp industry will also benefit, but we are proud that it is our Company that took action, fought the battle and won. We hope that this sets an important precedent for other EU jurisdictions where national medicine agencies have held a similar opinion,\u201d said Kannaway\u00ae Managing Director of International Janne Heimonen. \u201cWe have been fighting for many years now to prove that we are not, by law, selling medicine, but that our CBD oil is a nutritional supplement.\u201d<\/p>\r\n About Kannaway\u00ae<\/b><\/p>\r\n Kannaway\u00ae<\/a>\u00a0is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway\u00ae currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.<\/p>\r\n About Medical Marijuana, Inc.<\/b><\/p>\r\n We are a company of firsts\u00ae<\/a>. Medical Marijuana, Inc. (MJNA<\/a>) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by\u00a0Kannaway\u00ae<\/a>\u00a0and\u00a0HempMeds\u00ae<\/a>; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including\u00a0AXIM\u00ae Biotechnologies, Inc<\/a>.<\/a>\u00a0and\u00a0<\/a>Neuropathix<\/a>. Medical Marijuana, Inc. was named a top CBD producer by\u00a0CNBC<\/a>. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product\u00a0Real Scientific Hemp Oil<\/a>\u00a0has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.<\/p>\r\n Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at\u00a0OTCMarkets.com<\/a>\u00a0or by visiting\u00a0www.medicalmarijuanainc.com<\/a>. To see Medical Marijuana, Inc.'s corporate video,\u00a0click here<\/a>.<\/p>\r\n FORWARD-LOOKING DISCLAIMER<\/b><\/p>\r\n This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.<\/p>\r\n FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE<\/b><\/p>\r\n These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.<\/p>\r\n LEGAL DISCLOSURE<\/b><\/p>\r\n Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.<\/p>\r\n CONTACT:<\/b><\/p>\r\n Public Relations Contact:<\/b><\/p>\r\n Kathryn Brown\r\nAccount Director\r\nCMW Media\r\nP.\u00a0858-264-6600\r\nkathryn@cmwmedia.com\r\nwww.cmwmedia.com<\/a><\/p>\r\n Investor Relations Contact:<\/b><\/p>\r\n P.\u00a0(858) 283-4016\r\nInvestors@medicalmarijuanainc.com<\/p>","_et_gb_content_width":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-613","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases"],"yoast_head":"\n
\nAccount Director
\nCMW Media
\nP.\u00a0858-264-6600
\nkathryn@cmwmedia.com
\nwww.cmwmedia.com<\/a><\/p>\n
\nInvestors@medicalmarijuanainc.com<\/p>\n